X
01 MERCK KGAA (1)
02 Merck (Schweiz) AG (2)
03 Merck Germany, (2)
01 Ifl Protocol (3)
02 cetuximab (2)
01 Cetuximab 100Mg 20Ml 1 Units Parenteral Use (1)
02 INFUSIONSVÄTSKA, LÖSNING (2)
03 Infusion (2)
01 Italy (1)
02 Sweden (2)
03 Switzerland (2)
01 Erbitux (3)
02 Blank (2)